GlassScriptPhysician profile
Fahd Quddus
NPI 1952530677
$4,018.65
in general payments reported to CMS, 2019-2025
36 companies · $547 in 2025
The $547 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $991 · 2020: $202 · 2021: $344 · 2022: $405 · 2023: $243 · 2024: $1,286 · 2025: $547.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,180 · Long Term Medical Supply Or Device Loan: $781 · Education: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,180.35 |
| Long Term Medical Supply Or Device Loan | $781.23 |
| Education | $115.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $909.13 | 2019-2024 | |
| Janssen Biotech, INC. | $430.71 | 2019-2025 | Carvykti, Rybrevant, Darzalex |
| Mallinckrodt Hospital Products INC. | $257.38 | 2022-2023 | Uvadex |
| Astrazeneca Pharmaceuticals LP | $227.16 | 2020-2021 | |
| Glaxosmithkline, LLC. | $215.85 | 2021 | |
| Adaptive Biotechnologies Corporation | $177.39 | 2022-2024 | Clonoseq |
| Genzyme Corporation | $161.51 | 2019-2023 | |
| Amgen INC. | $148.05 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $146.53 | 2019-2022 | |
| Incyte Corporation | $123.80 | 2019-2025 | Niktimvo |
| Acrotech Biopharma INC. | $123.37 | 2024 | Beleodaq |
| Abbvie INC. | $121.20 | 2024 | |
| Kyowa Kirin, INC. | $118.02 | 2019 | |
| Mallinckrodt Enterprises LLC | $111.80 | 2019 | |
| Kite Pharma, INC. | $105.19 | 2020-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Servier Pharmaceuticals LLC | $100.91 | 2024 | |
| Pfizer INC. | $79.71 | 2019-2022 | |
| Ipsen Biopharmaceuticals, INC | $66.75 | 2019-2024 | Onivyde |
| Taiho Oncology, INC. | $52.39 | 2022-2023 | |
| Celgene Corporation | $42.59 | 2019-2023 | Pomalyst |
| Genentech USA, INC. | $40.04 | 2019-2022 | |
| Gilead Sciences, INC. | $38.38 | 2019-2023 | Trodelvy |
| Janssen Scientific Affairs, LLC | $33.68 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.46 | 2019-2022 | |
| Eisai INC. | $24.95 | 2019 | |
| Jazz Pharmaceuticals INC. | $19.86 | 2022 | |
| Merck Sharp & Dohme LLC | $17.29 | 2020 | |
| Pharmacyclics LLC, An Abbvie Company | $16.84 | 2019 | |
| Secura Bio, INC. | $15.06 | 2019 | |
| Astellas Pharma US INC | $12.72 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $12.51 | 2019 | |
| Karyopharm Therapeutics INC. | $12.21 | 2022 | |
| Emd Serono, INC. | $11.41 | 2020 | |
| Clovis Oncology, INC. | $10.80 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fahd Quddus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.